Top Midday Decliners
2:03PM ET 5/23/2022 MT NewswiresNymox Pharmaceutical (NYMX) said it received a refusal-to-file letter from the US Food and Drug Administration indicating the company needs to include...
Nymox Pharmaceutical (NYMX) said it received a refusal-to-file letter from the US Food and Drug Administration indicating the company needs to include...
Athersys (ATHX) shares shed about 18% in Monday afternoon trading after BofA Securities downgraded the stock to underperform from neutral and slashed its...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Athersys, Inc. (ATHX) shares are down more than 50% in premarket trading after the biotech company reported Friday that a study of its MultiStem ischemic...
Address | 3201 Carnegie Avenue Cleveland, Ohio 44115-2634 |
Phone | +1.216.431.9900 |
Number of Employees | 75 |
Recent SEC Filing | 05/12/2022![]() |
Chief Executive Officer & Director | Daniel A. Camardo |
President & Chief Operating Officer | William B. J. Lehmann |
Chief Financial & Accounting Officer | Ivor MacLeod |
Director, Chief Scientific Officer & Executive VP | John J. Harrington |
Price Open | $0.20 |
Previous Close | $0.18 |
52 Week Range | $0.18 - 1.81 |
Market Capitalization | $46.6 M |
Shares Outstanding | 252.0 M |
Sector | Health Technology |
Industry | Biotechnology | Next Earnings Announcement | 08/08/2022 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | N/A |
Earnings per Share | -$0.35 |
Beta vs. S&P 500 | N/A |
Revenue | $24.3 M |
Net Profit Margin | -981.52% |
Return on Equity | -429.24% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |